Page last updated: 2024-08-24

gemcitabine and bms 754807

gemcitabine has been researched along with bms 754807 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Awasthi, N; Ruan, W; Schwarz, MA; Schwarz, RE; Zhang, C	1

Other Studies

1 other study(ies) available for gemcitabine and bms 754807

Article	Year
BMS-754807, a small-molecule inhibitor of insulin-like growth factor-1 receptor/insulin receptor, enhances gemcitabine response in pancreatic cancer. Molecular cancer therapeutics, 2012, Volume: 11, Issue:12 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Growth Processes; Cell Line, Tumor; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Humans; Immunohistochemistry; Mice; Mice, Nude; Mice, SCID; Pancreatic Neoplasms; Pyrazoles; Random Allocation; Receptor, IGF Type 1; Signal Transduction; Triazines; Xenograft Model Antitumor Assays	2012

Article

Year

BMS-754807, a small-molecule inhibitor of insulin-like growth factor-1 receptor/insulin receptor, enhances gemcitabine response in pancreatic cancer.

Molecular cancer therapeutics, 2012, Volume: 11, Issue:12

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Growth Processes; Cell Line, Tumor; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Humans; Immunohistochemistry; Mice; Mice, Nude; Mice, SCID; Pancreatic Neoplasms; Pyrazoles; Random Allocation; Receptor, IGF Type 1; Signal Transduction; Triazines; Xenograft Model Antitumor Assays

2012